258 related articles for article (PubMed ID: 23800691)
21. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
22. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
23. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
[TBL] [Abstract][Full Text] [Related]
24. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
Lindberg D; Akerström G; Westin G
Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
[TBL] [Abstract][Full Text] [Related]
27. Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene.
Bugalho MJ; Domingues R
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26762354
[TBL] [Abstract][Full Text] [Related]
28. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
[TBL] [Abstract][Full Text] [Related]
29. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
[TBL] [Abstract][Full Text] [Related]
30. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M
J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521
[TBL] [Abstract][Full Text] [Related]
31. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
32. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract][Full Text] [Related]
33. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
[TBL] [Abstract][Full Text] [Related]
34. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
[TBL] [Abstract][Full Text] [Related]
35. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
[TBL] [Abstract][Full Text] [Related]
37. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
38. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
39. A patient with MEN1 typical features and MEN2-like features.
El-Maouche D; Welch J; Agarwal SK; Weinstein LS; Simonds WF; Marx SJ
Int J Endocr Oncol; 2016 May; 3(2):89-95. PubMed ID: 27594983
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
